PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. Chen X, Ruiz-Velasco A, Zou Z, Hille SS, et al. Diabetes 2024 Aug 13:db240240. doi: 10.2337/db24-0240.

Read + Share

Amedeo Smart

Independent Medical Education

Chen X, Ruiz-Velasco A, Zou Z, Hille SS, et al. PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. Diabetes 2024 Aug 13:db240240. doi: 10.2337/db24-0240.
PMID: 39137120